Enalare Therapeutics Nominated for Two Citeline Awards in Recognition of Outstanding Clinical Efforts

Enalare Therapeutics Inc., a clinical stage biopharmaceutical
company dedicated to developing novel compounds for the 
treatment of life-threatening critical care diseases and community health emergencies, announced today that it has been nominated for two prestigious Citeline Awards sponsored by Informa Pharma Intelligence in recognition of outstanding achievements in clinical research. Enalare is a finalist for the … Read more

Form Bio Names Linda Murray as Chief Financial Officer

Form Bio, the breakthrough computational life sciences platform, today announced the appointment of Linda Murray as Chief Financial Officer. “We are excited to announce this important addition to Form Bio’s leadership team as we enter an exciting time in our development and evolution; we’re growing rapidly as more cell and gene therapy companies discover what our … Read more

VUV Analytics Announces $20 Million Financing

VUV Analytics, Inc. announced today that it has raised $20 million in equity financing — led by existing investors S3 Ventures and New Science Ventures — bringing its total funding to over $36 million.  The announcement follows the recent launch of the company’s LUMA product and a record year for revenue with its unit sales … Read more

Rancho Biosciences Welcomes BenevolentAI as New Member to Its Single Cell Data Science Consortium

On Feb. 26, 2022, Rancho Biosciences, a leading data sciences services company, launched its Single Cell Data Science (SCDS) pre-competitive consortium, with four Charter Members: Bristol Myers Squibb, Janssen Research & Development, LLC, part of the Janssen Pharmaceutical Companies of Johnson & Johnson, Novartis and Vesalius Therapeutics. Today, Rancho Biosciences is pleased to announce the addition … Read more

Launch of LighthouseAI, an AI-Based Venture Unit to Solve Commercial Regulatory Compliance for the Life Sciences Industry

Pharma Solutions, a leading provider of compliance services in the life sciences industry, today announced the establishment of a new corporate venture unit and product suite, LighthouseAI™. LighthouseAI aims to solve compliance with a first-mover, AI-powered SaaS product suite that will fundamentally change the approach that the life sciences industry takes for compliance. This purpose-built … Read more

Blue Sky Specialty Pharmacy Gaines New URAC Rare Disease Status

Blue Sky Specialty Pharmacy, a leading innovator in the Specialty Pharmacy space, announced recently that they have just received the coveted URAC designation status pursuant to Rare Disease – Center of Excellence, Accreditation. URAC is the independent leader in promoting health care quality by setting high standards for clinical practice, consumer protections, performance measurement, operations … Read more

Health Care Consulting Leader Monument Analytics Will Change Its Name to Stage Analytics™

Health care consulting leader Monument Analytics announces that it has changed its name to Stage Analytics™. The new name captures the importance of Stage’s work, and it reflects the firm’s ongoing commitment to making a difference in the world by impacting every stage of life.  Stage Analytics is committed to providing the highest quality scientific … Read more

The World of Biolog Gets Bigger! Biolog Adds Contract Services and New Analysis Software to Its Portfolio of Tools With the Acquisition of MIDI Labs and MIDI, Inc.

Biolog, Inc., a leading provider of cell-based microbial identification and phenotypic profiling products, today announced the acquisition of MIDI Labs and MIDI, Inc., both headquartered in Newark, Delaware. Biolog and MIDI serve many of the same customers and industries. Over the last two decades, both companies have served the microbial ID community, offering complimentary products and … Read more

Form Bio Brings Accelerated Genomic Analysis to Bioinformatics with NVIDIA Clara Parabricks

Form Bio, the breakthrough computational life sciences platform, today announced the integration of the NVIDIA Clara Parabricks suite of genomic analysis tools with Form Bio’s genomic analysis workflows. The integrated solution, provided by Form Bio, enables scientists, bioinformaticians, and other life science professionals to execute genomic workflows with acceleration fueled by GPU parallelization and deep learning … Read more

Gb Sciences Addresses Growing Need for Anxiety and Depression Medications With Non-Psychedelic, Kava-Based Formulations

Gb Sciences, Inc. (OTCQB:GBLX), a leading plant-inspired, biopharmaceutical research and development company, is addressing the growing need for anxiety and depression medications through the development of novel, kava-inspired formulations, which are mood altering but non-hallucinogenic. Recently, Gb Sciences received positive preclinical results supporting the efficacy of its proprietary kava-based formulas designed for the treatment of … Read more